You can find other events in our calendar, or use the search:
European Antibody Congress
Geneve, Switzerland 27 – 29 November / 2012
Get entrance ticket to the trade show in advance. Choose the number of tickets, fill in a form and get them to your email.
|Free||− 1 +|
Unfortunately, we ran out of tickets and sincerely apologise for the inconvenience. But we have exhibitions you might like to attend.
This is a past event.
About the trade show
The European Antibody Congress is the world’s leading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Showcasing major antibody structural improvements, global trends, recent intra-market authorisation and clinical progress, this event sees unrivalled industry participation. Hear, learn, debate and act on the most critical scientific and business opportunities in the antibody sector.
The 250+ audience is primarily made up of Pharmaceutical companies and Biotechs. Supporting their projects, Technology Providers, CROs, CMOs and Researchers also attend. Over 50 leading scientists from Big Pharma and specialised biotech companies will share their expertise and groundbreaking conclusions throughout three jampacked days.
Speakers include: Merrimack Pharmaceuticals Inc, Schering Pharma AG, Lonza Custom Manufacturing, Wilex AG, Eli Lilly and Company, GenMab, Morphotek Inc, University of Zurich, Tufts Centre for the Study of Drug Development and mAbs journal, Ablynx, Kenta Biotech AG, Pfizer Global Biologics, CBER/FDA, Protagen AG, MedImmune, Roche Glycart AG, Icosagen Cell Factory OU, Johnson & Johnson, Fresenius Kabi, Bayer, Genentech, Inc, Centre d'Immunology and Vaccinex.